Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 5931-5940 Newer>

The Motley Fool February 22, 2005 Rich Smith	Time to Check the Plug What should investors be looking for in hydrogen fuel cell pioneer Plug Power's annual report?
The Motley Fool February 22, 2005 W.D. Crotty	A Do-It-Yourself Analysis Home Depot turns in another fine operating performance. At 18 times earnings, and a double-digit percentage increase in earnings on the way, the stock is value-priced.
The Motley Fool February 22, 2005 Rich Duprey	Merger Mania Besets Japanese Pharmaceuticals A new law spurs megamergers in Japan's pharmaceutical industry. Stocks of companies seen as particularly interesting, including Eisai, Mitsubishi Pharma, and Shionogi, all jumped more than 2%.
The Motley Fool February 22, 2005 Brian Gorman	Novartis Embraces Generics The company is taking a different path from its branded pharmaceutical peers. The company's strategy may make its stock worth a closer look.
The Motley Fool February 22, 2005 Alyce Lomax	Has Domino's Delivered? Earnings increase, but should investors look for a piece of this pie?
The Motley Fool February 22, 2005 Stephen D. Simpson	Hormel's Meaty Earnings Still thought of as a pork producer, Hormel has built a markedly diversified food business. Although the stock doesn't look like a screaming bargain today, long-term investors should probably sit tight.
The Motley Fool February 22, 2005 Tom Taulli	On-Demand Is in Demand Salesforce.com's Marc Benioff is the cheerleader of the software industry's latest thing. And customers seem to love it. On the news of the company's latest earnings report, investors pushed up the stock 13% to $15.95.
The Motley Fool February 22, 2005 Stephen D. Simpson	Will AGCO Reap Growth? Lower sales in South America could hamstring this agricultural equipment maker. Investors, take note.
The Motley Fool February 22, 2005 Stephen D. Simpson	Coventry Gets a Bad Rap The regional health management company takes a jump into national competition, but will profits follow? Coventry is at least worth a second look for most growth investors.
The Motley Fool February 22, 2005 Stephen D. Simpson	ABB's Long Road Back The Swiss power and automation conglomerate might be on the path to recovery. ABB shares might be interesting for patient investors with a long-term orientation and the ability to handle some risk in their portfolio
<Older 5931-5940 Newer> Return to current articles.